Vaishnaw Akshay
Insider CIK 1458494 · ALNY SVP, R&D · EDIT Director · SRRK President of R&D, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding Corp | S Sale | 2026-04-16 | 2026-04-20 | 12,246 | $49.57 | $607.0K | 630,542 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2026-02-09 | 2026-02-11 | 47,021 | — | $0 | 642,788 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2026-01-13 | 2026-01-15 | 20,438 | $42.70 | $872.7K | 595,767 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2025-05-29 | 2025-05-30 | 1,620 | $30.01 | $48.6K | 616,205 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2025-05-29 | 2025-05-30 | 5,130 | $29.63 | $152.0K | 617,825 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2025-05-02 | 2025-05-06 | 110,067 | — | $0 | 110,067 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2025-04-27 | 2025-04-29 | 500,000 | — | $0 | 622,955 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2025-04-27 | 2025-04-29 | 100,000 | — | $0 | 122,955 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 22,955 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 771 | $184.70 | $142.4K | 26,060 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 1,869 | $185.54 | $346.8K | 24,191 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 1,107 | $186.39 | $206.3K | 23,084 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 101 | $187.37 | $18.9K | 22,983 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 17 | $188.40 | $3.2K | 22,966 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 192 | $189.31 | $36.3K | 22,774 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-08-03 | 2023-08-07 | 3,859 | — | $0 | 26,831 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-08-03 | 2023-08-07 | 5,082 | — | $0 | 22,972 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2023-06-21 | 2023-06-22 | 36,000 | — | $0 | 36,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 1,013 | $194.94 | $197.5K | 18,162 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 104 | $195.65 | $20.3K | 18,058 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 168 | $197.08 | $33.1K | 17,890 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 910 | $193.93 | $176.5K | 19,175 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 197 | $193.18 | $38.1K | 20,085 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-04-26 | 2023-04-28 | 5,312 | — | $0 | 20,282 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 11,986 | — | $0 | 11,986 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 5,790 | — | $0 | 5,790 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-02-10 | 2023-02-14 | 30,913 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-10 | 2023-02-14 | 10,279 | $215.59 | $2.22M | 38,719 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-02-10 | 2023-02-14 | 30,913 | $63.00 | $1.95M | 53,014 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-10 | 2023-02-14 | 4,302 | $217.05 | $933.7K | 14,970 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-10 | 2023-02-14 | 19,447 | $216.38 | $4.21M | 19,272 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-10 | 2023-02-14 | 2,307 | $214.28 | $494.3K | 48,998 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-10 | 2023-02-14 | 1,709 | $213.13 | $364.2K | 51,305 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2022-12-05 | 2022-12-07 | 1,124 | — | $0 | 28,876 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2022-12-05 | 2022-12-07 | 1,587 | — | $0 | 30,913 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2022-12-05 | 2022-12-07 | 2,368 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2022-12-05 | 2022-12-07 | 1,587 | $63.00 | $100.0K | 21,057 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2022-12-05 | 2022-12-07 | 2,368 | $42.22 | $100.0K | 23,425 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-12-05 | 2022-12-07 | 1,324 | $226.20 | $299.5K | 22,101 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2022-12-05 | 2022-12-07 | 1,124 | $88.95 | $100.0K | 19,470 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 198 | $210.75 | $41.7K | 18,346 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 180 | $210.66 | $37.9K | 18,544 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 195 | $210.22 | $41.0K | 18,724 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 5,479 | $189.76 | $1.04M | 18,919 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 3,859 | — | $0 | 24,398 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 4,241 | — | $0 | 20,539 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 5,083 | — | $0 | 16,298 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2022-06-16 | 2022-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2022-05-26 | 2022-05-27 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-23 | 2022-02-25 | 29,842 | — | $0 | 29,842 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-12-31 | 2022-01-04 | 22,380 | — | $0 | 22,380 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 124 | $186.22 | $23.1K | 13,970 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 137 | $187.08 | $25.6K | 13,833 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 303 | $195.11 | $59.1K | 11,215 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 145 | $193.67 | $28.1K | 11,518 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 126 | $193.37 | $24.4K | 11,663 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 73 | $192.25 | $14.0K | 11,789 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 1,000 | $191.45 | $191.4K | 11,862 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 125 | $190.86 | $23.9K | 12,862 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 142 | $190.39 | $27.0K | 12,987 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 73 | $190.33 | $13.9K | 13,129 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 5 | $190.27 | $951 | 13,202 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 144 | $190.02 | $27.4K | 13,207 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 144 | $189.24 | $27.3K | 13,351 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 8 | $189.18 | $1.5K | 13,495 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 73 | $189.01 | $13.8K | 13,503 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 127 | $188.26 | $23.9K | 13,576 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-12-23 | 2021-12-23 | 130 | $187.35 | $24.4K | 13,703 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-12-22 | 2021-12-23 | 2,415 | $189.13 | $456.7K | 14,217 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-12-22 | 2021-12-23 | 1 | $190.50 | $191 | 14,216 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-12-22 | 2021-12-23 | 122 | $186.48 | $22.8K | 14,094 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-12-21 | 2021-12-23 | 5,417 | — | $0 | 16,632 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-08-09 | 2021-08-11 | 10,834 | — | $0 | 10,832 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-08-09 | 2021-08-11 | 10,834 | $200.00 | $2.17M | 11,215 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-08-09 | 2021-08-11 | 10,834 | $63.00 | $682.5K | 22,049 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-06-18 | 2021-06-22 | 10,834 | — | $0 | 21,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-06-18 | 2021-06-22 | 970 | — | $0 | 2,368 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-06-18 | 2021-06-22 | 10,834 | $63.00 | $682.5K | 24,953 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-06-18 | 2021-06-22 | 14,708 | $175.00 | $2.57M | 11,215 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-06-18 | 2021-06-22 | 970 | $42.22 | $41.0K | 25,923 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2021-06-03 | 2021-06-07 | 11,538 | — | $0 | 11,538 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2021-05-27 | 2021-06-01 | 7,800 | — | $0 | 7,800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-04-21 | 2021-04-21 | 107 | $138.48 | $14.8K | 14,119 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-04-21 | 2021-04-21 | 1,892 | $136.84 | $258.9K | 14,756 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-04-21 | 2021-04-21 | 530 | $137.60 | $72.9K | 14,226 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-04-21 | 2021-04-21 | 203 | $135.41 | $27.5K | 16,648 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 2,266 | $131.75 | $298.5K | 16,936 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 85 | $134.56 | $11.4K | 16,851 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-04-19 | 2021-04-21 | 622 | $138.64 | $86.2K | 19,619 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-04-19 | 2021-04-21 | 5,083 | — | $0 | 22,908 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-04-19 | 2021-04-21 | 1,678 | $136.76 | $229.5K | 21,230 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-04-19 | 2021-04-21 | 989 | $137.60 | $136.1K | 20,241 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-04-19 | 2021-04-21 | 417 | $140.02 | $58.4K | 19,202 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-02-24 | 2021-02-26 | 28,800 | — | $0 | 28,800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-02-12 | 2021-02-16 | 92 | $152.53 | $14.0K | 17,825 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-02-12 | 2021-02-16 | 1,618 | $156.00 | $252.4K | 17,917 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 8,334 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-02-11 | 2021-02-16 | 5,416 | — | $0 | 19,535 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-09-29 | 2020-10-01 | 971 | — | $0 | 3,338 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-09-29 | 2020-10-01 | 971 | $140.00 | $135.9K | 14,119 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-09-29 | 2020-10-01 | 971 | $42.22 | $41.0K | 15,090 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-06-22 | 2020-06-24 | 970 | — | $0 | 4,309 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-06-22 | 2020-06-24 | 195 | $152.97 | $29.8K | 14,119 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-06-22 | 2020-06-24 | 334 | $152.22 | $50.8K | 14,314 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-06-22 | 2020-06-24 | 970 | $42.22 | $41.0K | 15,089 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-06-22 | 2020-06-24 | 178 | $148.48 | $26.4K | 14,911 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-06-22 | 2020-06-24 | 83 | $149.09 | $12.4K | 14,828 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-06-22 | 2020-06-24 | 180 | $150.34 | $27.1K | 14,648 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2020-06-16 | 2020-06-18 | 13,000 | — | $0 | 13,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2020-06-10 | 2020-06-12 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-04-20 | 2020-04-22 | 971 | — | $0 | 5,279 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-04-20 | 2020-04-22 | 21,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-04-20 | 2020-04-22 | 21,000 | $42.22 | $886.6K | 35,119 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-04-20 | 2020-04-22 | 21,971 | $140.00 | $3.08M | 14,119 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-04-20 | 2020-04-22 | 971 | $42.22 | $41.0K | 36,090 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 98 | $106.52 | $10.4K | 14,119 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 2,415 | $104.75 | $253.0K | 14,217 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2020-04-07 | 2020-04-09 | 5,417 | — | $0 | 16,632 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-02-26 | 2020-02-28 | 27,623 | — | $0 | 27,623 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-02-07 | 2020-02-11 | 18,750 | — | $0 | 6,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-02-07 | 2020-02-11 | 4,000 | — | $0 | 21,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-07 | 2020-02-11 | 23,708 | $125.00 | $2.96M | 11,215 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-02-07 | 2020-02-11 | 18,750 | $42.22 | $791.6K | 30,923 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-02-07 | 2020-02-11 | 4,000 | $42.22 | $168.9K | 34,923 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-12-23 | 2019-12-26 | 8,333 | — | $0 | 16,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-11-22 | 2019-11-26 | 8,333 | — | $0 | 8,333 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-08-06 | 2019-08-07 | 7,500 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-08-06 | 2019-08-07 | 6,250 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-07-11 | 2019-08-07 | 48 | — | $0 | 515 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-06-05 | 2019-06-07 | 6,250 | — | $0 | 18,750 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2019-05-21 | 2019-05-23 | 20,316 | — | $0 | 20,316 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-04-09 | 2019-06-07 | 51 | — | $0 | 467 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-02-28 | 2019-03-01 | 32,500 | — | $0 | 32,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-10-18 | 2019-06-07 | 21 | — | $0 | 416 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 7,500 | — | $0 | 22,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 6,250 | — | $0 | 12,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-21 | 2018-08-23 | 7,500 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2018-08-13 | 2018-08-14 | 766 | $90.95 | $69.7K | 12,173 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2018-08-13 | 2018-08-14 | 1,724 | — | $0 | 12,939 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-10 | 2018-08-14 | 11,707 | — | $0 | 35,125 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-10 | 2018-08-14 | 10,832 | — | $0 | 32,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-07-10 | 2018-08-14 | 29 | — | $0 | 395 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2018-06-15 | 2018-06-19 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-04-16 | 2018-08-14 | 28 | — | $0 | 366 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-14 | 2018-03-16 | 44,641 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-14 | 2018-03-16 | 38,913 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-14 | 2018-03-16 | 5,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 15,000 | $141.69 | $2.13M | 78,316 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-14 | 2018-03-16 | 5,000 | $7.10 | $35.5K | 99,769 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-14 | 2018-03-16 | 38,913 | $16.43 | $639.3K | 94,769 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-14 | 2018-03-16 | 44,641 | $18.66 | $833.0K | 55,856 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 6,380 | $145.27 | $926.8K | 11,215 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 20,172 | $144.53 | $2.92M | 17,595 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 19,213 | $143.46 | $2.76M | 37,767 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 21,336 | $142.57 | $3.04M | 56,980 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 6,453 | $140.45 | $906.3K | 93,316 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-03-01 | 2018-03-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-12-20 | 2017-12-21 | 6,250 | — | $0 | 6,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2017-12-19 | 2017-12-21 | 320 | — | $0 | 11,215 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-11-06 | 2017-11-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-10-30 | 2017-11-01 | 33,666 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-10-30 | 2017-11-01 | 33,666 | $21.35 | $718.8K | 45,201 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-10-30 | 2017-11-01 | 800 | $119.79 | $95.8K | 44,401 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-10-30 | 2017-11-01 | 11,418 | $120.78 | $1.38M | 32,983 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-10-30 | 2017-11-01 | 3,693 | $122.79 | $453.5K | 11,535 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-10-30 | 2017-11-01 | 17,755 | $121.69 | $2.16M | 15,228 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-09-20 | 2017-09-22 | 10,834 | — | $0 | 10,834 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-07-07 | 2017-07-11 | 11,709 | — | $0 | 23,418 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-06-13 | 2017-06-15 | 328 | — | $0 | 33,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-06-13 | 2017-06-15 | 1,340 | — | $0 | 44,641 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-06-13 | 2017-06-15 | 1,340 | $18.66 | $25.0K | 11,965 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2017-06-13 | 2017-06-15 | 430 | $74.31 | $32.0K | 11,535 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-06-13 | 2017-06-15 | 328 | $21.35 | $7.0K | 10,625 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-05-23 | 2017-05-25 | 11,000 | — | $0 | 33,994 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-05-23 | 2017-05-25 | 11,000 | $21.35 | $234.9K | 21,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-05-23 | 2017-05-25 | 11,000 | $75.00 | $825.0K | 10,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-05-15 | 2017-05-17 | 32,750 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-05-15 | 2017-05-17 | 11,000 | — | $0 | 44,994 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-05-15 | 2017-05-17 | 11,000 | $21.35 | $234.9K | 21,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-05-15 | 2017-05-17 | 32,750 | $31.39 | $1.03M | 43,047 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-05-15 | 2017-05-17 | 32,750 | $65.00 | $2.13M | 10,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-05-15 | 2017-05-17 | 11,000 | $65.00 | $715.0K | 10,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-12-30 | 2017-01-04 | 4,356 | — | $0 | 55,994 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-12-30 | 2017-01-04 | 4,019 | — | $0 | 45,981 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-12-30 | 2017-01-04 | 1,172 | — | $0 | 38,913 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2016-12-30 | 2017-01-04 | 5,000 | $37.44 | $187.2K | 10,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-12-30 | 2017-01-04 | 4,356 | $21.35 | $93.0K | 15,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-12-30 | 2017-01-04 | 4,019 | $18.66 | $75.0K | 10,941 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-12-30 | 2017-01-04 | 1,172 | $16.43 | $19.3K | 6,922 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-12-20 | 2016-12-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-11-30 | 2016-12-02 | 29,165 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-11-30 | 2016-12-02 | 29,165 | $22.75 | $663.5K | 34,915 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-11-30 | 2016-12-02 | 1,500 | $46.14 | $69.2K | 5,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-11-30 | 2016-12-02 | 13,297 | $45.55 | $605.7K | 7,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-11-30 | 2016-12-02 | 14,368 | $44.34 | $637.1K | 20,547 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2016-07-28 | 2016-07-29 | 23,076 | — | $0 | 23,076 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-02-23 | 2016-02-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-02-01 | 2016-02-03 | 11,709 | — | $0 | 11,709 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-12-18 | 2015-12-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-11-25 | 2015-11-30 | 4,915 | — | $0 | 40,085 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-11-25 | 2015-11-30 | 835 | — | $0 | 29,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-11-25 | 2015-11-30 | 4,915 | $16.43 | $80.8K | 5,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-11-25 | 2015-11-30 | 835 | $22.75 | $19.0K | 835 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-06-16 | 2015-06-18 | 6,250 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-06-16 | 2015-06-18 | 2,500 | — | $0 | 5,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-06-16 | 2015-06-18 | 350 | $131.00 | $45.9K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-06-16 | 2015-06-18 | 1,800 | $130.06 | $234.1K | 350 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-06-16 | 2015-06-18 | 2,667 | $128.79 | $343.5K | 2,150 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-06-16 | 2015-06-18 | 3,933 | $128.10 | $503.8K | 4,817 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-06-16 | 2015-06-18 | 2,500 | $7.10 | $17.8K | 8,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-06-16 | 2015-06-18 | 6,250 | $9.30 | $58.1K | 6,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-05-01 | 2015-05-05 | 35,125 | — | $0 | 35,125 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-03-17 | 2015-03-19 | 2,500 | — | $0 | 7,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-03-17 | 2015-03-19 | 6,250 | — | $0 | 6,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-03-17 | 2015-03-19 | 644 | $119.38 | $76.9K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-03-17 | 2015-03-19 | 1,000 | $118.16 | $118.2K | 644 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-03-17 | 2015-03-19 | 2,080 | $117.35 | $244.1K | 1,644 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-03-17 | 2015-03-19 | 3,802 | $116.34 | $442.3K | 3,724 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-03-17 | 2015-03-19 | 1,224 | $115.29 | $141.1K | 7,526 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-03-17 | 2015-03-19 | 6,250 | $9.30 | $58.1K | 6,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-03-17 | 2015-03-19 | 2,500 | $7.10 | $17.8K | 8,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-16 | 2014-12-16 | 2,500 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-16 | 2014-12-16 | 1,875 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-16 | 2014-12-16 | 6,251 | — | $0 | 12,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-16 | 2014-12-16 | 2,936 | $93.42 | $274.3K | 5,190 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-16 | 2014-12-16 | 1,875 | $9.14 | $17.1K | 1,875 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-16 | 2014-12-16 | 6,251 | $9.30 | $58.1K | 8,126 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-16 | 2014-12-16 | 2,500 | $7.10 | $17.8K | 10,626 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-16 | 2014-12-16 | 600 | $91.47 | $54.9K | 10,026 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-16 | 2014-12-16 | 1,900 | $92.33 | $175.4K | 8,126 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-16 | 2014-12-16 | 100 | $95.00 | $9.5K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-16 | 2014-12-16 | 5,090 | $94.40 | $480.5K | 100 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-12-12 | 2014-12-16 | 10,834 | — | $0 | 10,834 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-09-16 | 2014-09-17 | 6,250 | — | $0 | 18,751 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-09-16 | 2014-09-17 | 1,875 | — | $0 | 1,875 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-09-16 | 2014-09-17 | 2,500 | — | $0 | 12,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-09-16 | 2014-09-17 | 800 | $73.03 | $58.4K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-09-16 | 2014-09-17 | 6,625 | $72.27 | $478.8K | 800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-09-16 | 2014-09-17 | 3,200 | $71.34 | $228.3K | 7,425 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-09-16 | 2014-09-17 | 2,500 | $7.10 | $17.8K | 10,625 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-09-16 | 2014-09-17 | 6,250 | $9.30 | $58.1K | 8,125 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-09-16 | 2014-09-17 | 1,875 | $9.14 | $17.1K | 1,875 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-06-17 | 2014-06-19 | 6,250 | — | $0 | 25,001 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-06-17 | 2014-06-19 | 1,875 | — | $0 | 3,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-06-17 | 2014-06-19 | 2,500 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-06-17 | 2014-06-19 | 6,250 | $9.30 | $58.1K | 10,625 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-06-17 | 2014-06-19 | 2,500 | $7.10 | $17.8K | 4,375 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-06-17 | 2014-06-19 | 8,127 | $69.97 | $568.6K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-06-17 | 2014-06-19 | 2,498 | $69.33 | $173.2K | 8,127 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-06-17 | 2014-06-19 | 1,875 | $9.14 | $17.1K | 1,875 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-03-18 | 2014-03-20 | 1,875 | — | $0 | 5,625 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-03-18 | 2014-03-20 | 6,249 | — | $0 | 31,251 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-03-18 | 2014-03-20 | 22,145 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-03-18 | 2014-03-20 | 2,500 | — | $0 | 17,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-03-18 | 2014-03-20 | 1,944 | $75.15 | $146.1K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-03-18 | 2014-03-20 | 22,044 | $74.08 | $1.63M | 1,944 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-03-18 | 2014-03-20 | 8,781 | $73.34 | $644.0K | 23,988 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-03-18 | 2014-03-20 | 2,500 | $7.10 | $17.8K | 32,769 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-03-18 | 2014-03-20 | 6,249 | $9.30 | $58.1K | 30,269 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-03-18 | 2014-03-20 | 1,875 | $9.14 | $17.1K | 24,020 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-03-18 | 2014-03-20 | 22,145 | $12.96 | $287.0K | 22,145 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | I Discretionary | 2014-02-21 | 2014-02-25 | 2,615 | $90.10 | $235.6K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-01-24 | 2014-01-27 | 1,869 | $84.57 | $158.1K | 6,021 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-01-24 | 2014-01-27 | 1,100 | $86.60 | $95.3K | 700 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-01-24 | 2014-01-27 | 700 | $87.44 | $61.2K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-01-24 | 2014-01-27 | 4,221 | $85.77 | $362.0K | 1,800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2014-01-23 | 2014-01-27 | 4,698 | $89.49 | $420.4K | 7,890 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-12-18 | 2013-12-18 | 32,500 | — | $0 | 32,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-17 | 2013-12-18 | 18,480 | — | $0 | 22,145 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-12-17 | 2013-12-18 | 8,500 | $60.59 | $515.0K | 22,568 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-17 | 2013-12-18 | 18,480 | $12.96 | $239.5K | 31,068 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-12-17 | 2013-12-18 | 9,980 | $61.40 | $612.8K | 12,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-16 | 2013-12-18 | 6,250 | — | $0 | 37,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-16 | 2013-12-18 | 3,750 | — | $0 | 7,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-16 | 2013-12-18 | 5,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-16 | 2013-12-18 | 3,750 | $9.14 | $34.3K | 16,338 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-16 | 2013-12-18 | 6,250 | $9.30 | $58.1K | 22,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-16 | 2013-12-18 | 5,000 | $7.10 | $35.5K | 27,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-12-16 | 2013-12-18 | 4,256 | $60.78 | $258.7K | 12,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-12-16 | 2013-12-18 | 10,744 | $60.19 | $646.7K | 16,844 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-09-10 | 2013-09-12 | 6,250 | — | $0 | 43,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-09-10 | 2013-09-12 | 700 | $58.18 | $40.7K | 12,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-09-10 | 2013-09-12 | 5,550 | $57.39 | $318.5K | 13,288 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-09-10 | 2013-09-12 | 6,250 | $9.30 | $58.1K | 18,838 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-06-11 | 2013-06-13 | 6,250 | — | $0 | 50,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-06-11 | 2013-06-13 | 5,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-06-11 | 2013-06-13 | 3,750 | — | $0 | 11,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-06-11 | 2013-06-13 | 4,900 | $31.07 | $152.2K | 12,688 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-06-11 | 2013-06-13 | 100 | $31.75 | $3.2K | 12,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-06-11 | 2013-06-13 | 5,000 | $7.10 | $35.5K | 17,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-06-11 | 2013-06-13 | 6,250 | $31.07 | $194.2K | 12,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-06-11 | 2013-06-13 | 6,250 | $9.30 | $58.1K | 18,838 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-06-11 | 2013-06-13 | 3,750 | $31.07 | $116.5K | 12,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-06-11 | 2013-06-13 | 3,750 | $9.14 | $34.3K | 16,338 | SEC↗ |